CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 176 filers reported holding CLOVIS ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $13,000 | -27.8% | 200 | -50.0% | 0.00% | -20.0% |
| Q4 2016 | $18,000 | +28.6% | 400 | 0.0% | 0.01% | +25.0% |
| Q3 2016 | $14,000 | +180.0% | 400 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $5,000 | -37.5% | 400 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $8,000 | -42.9% | 400 | 0.0% | 0.00% | -40.0% |
| Q4 2015 | $14,000 | – | 400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |